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Understanding SARS-CoV-2 features of infectivity, aggressiveness, and 
transmissibility: an insect-vector theory for SARS-CoV-2 
dissemination  
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Abstract   
 
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a ribonucleic acid–based (RNA-based) lineage 
B β-coronavirus characterized by 10-20 times higher infectivity and transmissibility even across species than previous 
coronaviruses. The significant infectivity rate of SARS-CoV-2 is due to its different host cell entry mechanisms that are 
mainly via angiotensin-converting enzyme 2 (ACE2) receptors contrasting earlier coronaviruses that used mainly the 
endosomal route. Due to the widespread distribution of ACE2 receptors throughout our body, various routes of 
infectivity are possible, highlighting the necessity of employing multiple forms of protection besides face masks to limit 
inter-human transmissibility. SARS-CoV-2 exhibits other remarkable features such as the ability to escape the immune 
system repeated genomic mutations that make it difficult to design a vaccine to address all viral strains and form huge 
host cell syncytia leading to massive tissue destruction. If we accept SARS-CoV-2 primary reservoir from bats, we 
should investigate the routes of viral inter-species propagation. In this article, a new theory is proposed- that the 
dissemination of the virus from the bats to other species and humans could have been possible via an insect vector, as 
insects possess significant amounts of both ACE2 receptors and a disintegrin and metalloprotease 17 (ADAM-17) 
enzymes that are essential for virus infectivity. 
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Background  
The severe acute respiratory syndrome coronavirus 2  (SARS-
CoV-2) is a ribonucleic acid-based (RNA-based) lineage B β-
coronavirus, similar to other genetically related coronaviruses 
such as severe acute respiratory coronavirus (SARS-CoV), 
Middle East respiratory syndrome coronavirus (MERS), and 
several bat coronaviruses, that has currently become the major 
world health problem. Contrasting SARS-CoV and MERS that 
generated pandemics in 2002-2003 and 2015, SARS-CoV-2 is 
far more aggressive, characterized by 10-20 times higher 
infectivity and transmissibility even across species and 
devastating mortality rates [1-4] that left humanity without 
efficient solutions and resources. The outstanding 
aggressiveness of SARS-CoV-2 contrasting previous SARS 
viruses is due to several mutations that have provided this virus 
with the incredible ability to recognize ACE2 receptors in host 
cells and mediate its cell entry via this route [5,6],  gaining a 
key that opens all doors. This way of cell entry is unique for 
SARS-CoV-2, as previous SARS coronaviruses mainly used the 
endosomal pathway of cellular entry, a less efficient route 
because it triggers a defensive and offensive host immune 
response.  Instead, cell entry via ACE2 receptors is far more 
insidious as virus entry is mediated, "invited" by its apparent 
acquaintance to host ACE2. ACE2 entry route is a very 
advantageous modality as these receptors are extremely 
abundant throughout the body, being present on all vascular 
endothelial cells, not only pulmonary but of all organs (heart, 
kidney, liver, testicular, etc.). ACE2 is also expressed on 
epithelial cells- alveolar cells type I and II, but even red blood 
cells, digestive tract cells (from mouth cavity throughout 
digestive tract), mucosae (important quantities on nasal mucosa 
or cornea) [7-9]. This impressive expression of ACE2 receptors 
throughout our body explains the possible ways of human 
infectivity via respiratory or corneal pathways and putative 
digestive, fecal-oral contamination, as described in bats or by 
contact with contaminated blood or urine. The high corneal 
density of ACE2 receptors highlights the necessity of wearing 
protective eyeglasses to prevent another important route of 
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inter-human infectivity, maybe as important as the wear of a 
face mask.  
     Moreover, the finding that there is a high density of 
testicular ACE2 receptors in humans [4] brings into question an 
additional putative sexual transmission route of infection and 
the post-COVID-19 risk of male infertility that should be 
addressed by future research in extended studies. The SARS-
CoV-2 features of aggressiveness and escape from the human 
immune system. Besides the increased affinity towards the 
ACE2 receptors, another feature of aggressiveness that 
distinguishes the SARS-CoV-2 from previous coronaviruses is 
its ability to form huge cell syncytia. This process leads to 
important host tissue loss and inflammatory immune response. 
The positive feedback in the inflammatory loop supplementary 
increases virus-mediated destruction and leads to subsequent 
fibrotic sequelae [5].  
     Additionally, in SARS-CoV-2 disease, host immune 
response and developed antibodies are not efficiently protective, 
and SARS-CoV-2 hijacks immune cells to disseminate 
throughout the body. Even in this feature, SARS-CoV-2 
outstands as it can exploit host immune response- the 
antibodies-to increase its entry into immune cells, such as 
macrophages and probably lymphocytes – a process that is 
called antibody-dependent enhancement of coronavirus entry 
[8]. In this mechanism, antiviral antibodies do not destroy the 
pathogenic agent, but after being linked to the virus, they 
mediate its entry into the immune cells via Fc-receptors [6].  
The SARS-CoV-2 antibody-dependent enhancement of 
coronavirus entry into the host cells explains why an effective 
vaccine is difficult to be developed in the near future. The 
possibility of an effective vaccine design for all the SARS-
CoV-2 strains in the near future is also pale as this type of 
coronavirus has a huge registry of immune escape possibilities. 
This type of virus acquires systematic, repeated genomic 
mutations in time, between geographic regions, between 
individuals, and intra-individually, across time, 103 recent 
SARS-CoV-2 genomes being already described [4, 6]. This 
feature is similar to the hepatitis C virus (HCV), a virus against 
which, despite time, no vaccine has been designed. Therefore, 
SARS-CoV-2 disease is a serious global health problem of 
present and future from several points of view: high associated 
mortality rates, unpredictable effects in apparently cured 
people, and the possibility to reemerge in the future in even 
more aggressive forms, the result of additional genomic 
mutations and evolutionary selection of genes.  
    Naturally, as SARS-CoV-2 escapes and is even enhanced by 
immune system mechanisms, being ultimately harbored in 
immune cells such as macrophages and lymphocytes, a major 
concern of humanity is the possibility of insidious viral survival 
in human cells of apparently healed individuals and of 
systematically reemerging (apparent reinfections). The 
subsequent reinfections, paralleled by a decrease in the host 
immune cell number, would ultimately lead to the infected 
individual's death, just like in the progression of an HIV 
infection. The SARS-CoV-2 transmission routes across species 
Knowledge of SARS-CoV-2 transmission routes across species 
and between individuals is essential for effective prevention and 
surveillance of the population, especially those at increased risk 
due to their comorbidities, such as cardiovascular and metabolic 
diseases.   
    Currently, there are persisting controversies on SARS-CoV-2 
initial origin and dissemination across species. Some authors 
consider that SARS-CoV-2 features that are at the base of its 
infectivity are unlikely to be determined by spontaneous 
evolutionary viral gain, although others disagree in this matter 
[5]. If natural selection and genomic mutations represent the 
actual mechanism behind SARS-CoV-2 evolution, it should 
normally result from a very prolonged period, not only a few 
months. Many of us would have already been infected in this 
scenario, and any person could be patient zero. However, others 
have suspected that SARS-CoV-2 could be the product of 
human refinement, appearing like an engineered entity based on 
an original vector that received genomic insertions to overcome 
the human body's important defense barriers.  
     In this regard, SARS-CoV-2 acquired features that 
distinguish it from SARS-CoV, MERS, and bat coronaviruses 
and render it possibilities for infectivity a cross-species, such as 
genomic sequences similar to HIV Ebola, HCV viruses and gain 
towards recognizing ACE2 receptors with the high affinity. 
These features appear as too evolved mechanisms to arise by 
random selections and create a pandemic in only a few months. 
If we accept the initial origin of SARS-CoV-2 from bats that are 
known to be natural concentrated reservoirs of various 
extremely dangerous viruses (coronaviruses, hepatitis C viruses, 
HIV), because these bats live in crowded communities where 
inter-individual viral transmission is easy, still we cannot 
explain the transmission of such a virus to humans or other 
animals (rodents, cats, dogs, etc.) [1,5,10-14]. 
    Until now, the SARS-CoV-2 has been isolated from many 
animals besides humans and bats, such as domestic (dogs, cats) 
and farm animals (pigs, chicken, duck, wildlife (birds, exotic 
animals (many consumed in Chinese cuisine) such as snakes, 
cats, Chinese bamboo rats, raccoon dogs, civet cats, monkeys 
but the transmission mechanisms between species are unknown 
yet [14,15].  The putative animal vectors incriminated up to 
now (snakes, pangolins, civet cats, and raccoon dogs that 
represent exotic food in China) have been exonerated afterward.  
In this setting, our opinion is that the virus's putative initial 
carrier across species could be an insect. Insects have important 
numbers of ACE2 receptors (evolutionarily conserved proteins, 
although insufficiently described) [16-19], but also of ADAM-
17 enzymes, essential for the viral and ACE2 activation [20]. 
Considering their important extension and numbers (there are 
hematophagous parasitic insects even on bats), insects could 
contribute to viral dissemination across species. Warm weather, 
such as in subtropical Wuhan, could have initially contributed 
to insect cycle progression, human dissemination of the virus, 
and a higher infectivity rate observed in certain countries 
contrasting others. 
     An insect-vector-driven virus theory could explain why 
malaria-endemic countries and the degree of SARS-CoV-2 
infectivity are lower than expected [21,22]. Although anti-
malarial medicines have not been found to have definitive 
positive effects on COVID disease, people use insect repellants 
more frequently, contrasting with other geographic regions in 
these countries. Currently, there is a persistent global 
apprehension regarding the vector-borne diseases of zoonotic 
origin that can acquire mutations and repeatedly reemerge, 
creating pandemics. It is already acknowledged that insect 
vectors such as mosquitos, ticks, blackflies, sandflies, tsetse 
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flies, fleas, lice, triatomine bugs are responsible for many feared 
infectious diseases, including malaria, dengue, chikungunya, 
Zika virus, yellow, West Nile fever, Japanese encephalitis, tick-
borne encephalitis, leishmaniasis, Chagas disease (around 
700,000 human deaths each year) [23]. Therefore, these insect 
vectors can transmit viruses, bacteria, protozoa, fungi, and 
parasites to humans, domestic and wild animals. The 
transmission can be biological, blood-borne (for bloodsucking 
insects), but also mechanical, where the insect acts as a carrier 
(on its legs, mouthpart, feces, vomit, hairs), although it never 
develops the infection [13]. 
    There are reports that the house flies (Musca domestica 
Linnaeus) can mechanically transmit coronaviruses (such as 
turkey coronavirus, the agent of a very severe enteric infection 
of turkeys; pig coronavirus - agent of pig gastroenteritis) being 
therefore responsible for the viral dissemination within the same 
species, but putatively also across species. In fact, house flies 
can act as vectors for more than 30 infectious diseases (viral, 
bacterial, and protozoan)[15,24]. Besides coronaviruses, it is 
known that flies can also act as carriers for avian influenza 
viruses H5N7 and H7N1, which can persist in their alimentary 
tracts [25]. Also, the housefly can transport on its body the 
Newcastle disease virus, and it can harbor it for up to 96 hours 
[26]. Therefore, further research studies on this aspect should 
take into consideration that in many insect vectors, the viruses 
do not persist for extended periods, and the efficient time 
window for the study is limited. This ability of the house fly to 
act in the mechanical transmission of diseases has several 
explanations: their ubiquitous presence in large numbers (in the 
human houses, farms, domestic animals feeders and drinkers, 
but also in the wild environment); feeding behavior- flies 
frequently defecate and regurgitate/vomit while feeding; their 
common food is represented by putative coronavirus reservoirs 
such as human and animal feces, dried and fresh blood, sputum, 
respiratory secretions, dead birds, various corpses; also, carriage 
of the viruses via housefly exoskeleton; the constant movement 
of flies across food- surfaces- humans- animals; important 
areal- capable of covering up to 11.8 km in 24 hours. 
     The turkey coronavirus (earlier coronavirus) can persist in a 
viable form in the housefly's crop for an important period of 9 
hours, creating a time window when it can further transmit the 
virus [27]. Even more, flies do not develop the infection, 
making them capable of transporting the infective agents along 
their life cycle [15, 25-27]. Some authors also consider 
cockroaches as putative vectors for coronaviruses by similar 
mechanisms to houseflies [13]. Mosquitos are also known to 
transmit to humans many single-stranded RNA viruses. As they 
feed on multiple species, including bats known as coronaviruses 
reservoirs, they could potentially play a role in disseminating 
coronaviruses and other types of feared viruses (e.g., Yellow 
fever; equine encephalitis, where the mosquitos transmit the 
infective agent from birds) across species. Even more, many of 
the arthropod-transmitted viruses express an important capacity 
to undergo mutations and gain specific host virulence [24]. 
Other authors have found earlier coronavirus-derived RNA and 
proteins in the midgut of the domestic cat flea (Ctenocephalides 
felis) (which is a known vector for many feared pathogens 
(Yersinia pestis, Rickettsia typhi, Bartonella spp., tapeworms, 
and filarial nematodes). This suggests that the coronaviruses 
could persist and replicate into fleas and act as biological and 
mechanical vectors of the disease across an important range of 
species, including the initial transmission from bats to other 
species. Also, a coronavirus-like agent was isolated in the tick 
of seabirds, responsible for the fatal peritonitis in cats [19].  
Even moths could act as vectors for the coronaviruses, although 
studies on this aspect are currently missing. These data clearly 
suggest that insects can transmit earlier coronaviruses across 
animal species. Therefore, it is logical to suspect that they could 
have acted/ could still act as vectors for the SARS-CoV-2 and 
disseminate it across the animal species and humans. 
 
The increased need for SARS-CoV-2 dissemination 
preventing strategies in front of the lack of efficient and 
specific therapies  
Various types of therapies have been proposed for SARS-CoV-
2 disease. However, none of them is specific for SARS-CoV-2 
treatment, nor has it led to definitive and clear beneficial results 
[13]. As SARS-CoV-2 does not use the same mechanism of cell 
entry as other well-described viruses and there is an antibody-
mediated enhanced viral entry into the host cells, most of the 
proposed drugs appear not only to be inefficient but even 
potentially dangerous. Unless human plasma of cured patients 
contains an impressive titer of antiviral antibodies, an average, 
variable in time antiviral antibody titer (sub-neutralizing titer) 
would potentially become harmful. Moreover, if we consider 
the antibody-dependent enhancement of coronavirus entry into 
the host cells, a vaccine could increase viral infectivity [8]. 
Anti-malarial drugs, especially Artemisia-based ones, appeared 
at a certain point to be more promising, as they destroyed big 
foreign particles already entered into the cell by a partially 
described mechanism [28]. However, the results are mixed as 
these drugs do not appear to prevent cell infection and 
massively destroyed infected cells containing the viruses trigger 
a massive inflammatory immune response overpassing the 
biological resources in severe cases. Also, the design of an 
efficient, specific therapy is difficult because the exact detailed 
mechanism of viral infectivity is insufficiently understood, 
including knowledge on the exact protease to activate the 
SARS-CoV-2 [29]. Facing these therapeutic limitations and in 
front of the many uncertainties regarding the detailed 
mechanism of SARS-CoV-2 infectivity, knowledge of the inter-
human and across species viral dissemination would become an 
extremely powerful tool in the control of the COVID-19 
pandemics [13]. In this light, the prevention/decrease of human 
exposure to various insect-vectors, including fleas, ticks, 
mosquitos, houseflies, and cockroaches, may spread various 
infective pathogens coronaviruses via various control methods 
(mechanical, physical, and even chemical) appears as a logical 
necessity.   
 
Conclusion  
In conclusion, a potential vector to disseminate the SARS-CoV-
2 across species can be insects, as insects express extraordinary 
amounts of ACE2. In this context, future dedicated 
investigation of a putative insect-vector transmission route 
possibility appears essential. As the origins of SARS-CoV-2 
remain enigmatic, subject of debates and suspiciousness, 
understanding the exact mechanism leading to infection 
propagation across species could bring unexpected promising 
therapeutic perspectives, including public infection prevention 
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and control. Also, previous studies have not investigated all the 
putative ways of infectivity across individuals.   
     Naturally, as SARS-CoV-2 escapes the immune system 
mechanisms, a major concern of humanity is the possibility of 
insidious viral survival in human cells of apparently healed 
individuals and of systematically reemerging (apparent 
reinfections), ultimately leading to the extinct of the infected 
individual. In the absence of a therapeutic escape, our future 
(not only for one-two years) is uncertain, as the intelligence of 
this type of virus and its evolutionary features imply that it 
could recur in repeated pandemics, under more and more 
aggressive forms, but over a world that is more and more 
depleted of human and material resources. 
 
Abbreviation  
SARS-CoV: Severe Acute Respiratory Syndrome Coronavirus; 
SARS-CoV-2: Severe Acute Respiratory Syndrome 
Coronavirus 2; MERS: The Middle East Respiratory Syndrome 
Coronavirus; COVID-19: The Coronavirus Disease 19; ACE2: 
Angiotensin-Converting Enzyme 2; ADAM-17: A Disintegrin 
and Metalloprotease 17, also known as TACE (Tumor Necrosis 
Factor-Alpha -Converting Enzyme); HCV: hepatitis C virus; 
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